Arcus biosciences to participate in two upcoming investor conferences

Hayward, calif.--(business wire)--arcus biosciences (nyse:rcus), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in the following upcoming investor conferences in march: leerink global biopharma conference 2024 date: monday, march 11th, 2024 at 4:00 p.m. et location: miami beach, fl format: fireside chat barclays 26th annual global healthcare co.
RCUS Ratings Summary
RCUS Quant Ranking